Juno Therapeutics, Inc.
Overview
Juno Therapeutics, Inc. is a subsidiary of Bristol-Myers Squibb Company that focuses on developing innovative immunotherapies for the treatment of cancer. The company leverages advanced technologies to enhance the body’s immune system in targeting cancer cells.
Therapeutic areas
FDA compliance signals
3 FDA enforcement records linked to this company.
- 4832023-09-20
Procedures not in writing, fully followed
- 4832023-09-20
Procedures for sterile drug products
- 4832023-09-20
Written procedures not established/followed
Related companies
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
Fred Hutchinson Cancer Center
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.